Hiroyuki Shiro
- Microbiology top 5%
- Bacterial Infections and Vaccines 5
- Clinical Biochemistry top 10%
- Infectious Diseases top 10%
- Antimicrobial Resistance in Staphylococcus 5
- Molecular Medicine top 10%
-
- Pneumonia and Respiratory Infections 9
- Respiratory viral infections research 3
- Infective Endocarditis Diagnosis and Management 2
-
- Antibiotics Pharmacokinetics and Efficacy 3
-
- Respiratory and Cough-Related Research 2
-
- Streptococcal Infections and Treatments 2
Hiroyuki Shiro
21 papers receiving 414 citations
Peers
Comparison fields: 5 of 57
- Microbiology 94
- Clinical Biochemistry 68
- Infectious Diseases 182
- Applied Microbiology and Biotechnology 15
- Molecular Medicine 35
Countries citing papers authored by Hiroyuki Shiro
This map shows the geographic impact of Hiroyuki Shiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Shiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Shiro more than expected).
Fields of papers citing papers by Hiroyuki Shiro
This network shows the impact of papers produced by Hiroyuki Shiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Shiro. The network helps show where Hiroyuki Shiro may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroyuki Shiro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 7 | |
| 2 | 2020 | 9 | |
| 3 | 2020 | 5 | |
| 4 | 2019 | 20 | |
| 5 | 2018 | 10 | |
| 6 | 2017 | 25 | |
| 7 | 2015 | 0 | |
| 8 | 2014 | 32 | |
| 9 | 2011 | 3 | |
| 10 | 2010 | 13 | |
| 11 | Three cases of purulent meningitis caused by Listeria monocytogenes | 2008 | 1 |
| 12 | 2008 | 3 | |
| 13 | 2006 | 21 | |
| 14 | Arbekacin postmarketing clinical study | 2003 | 1 |
| 15 | 1995 | 18 | |
| 16 | 1995 | 22 | |
| 17 | 1994 | 89 | |
| 18 | 1994 | 64 | |
| 19 | 1993 | 77 | |
| 20 | [Comparative, controlled study on an ampicillin suppository (KS-R 1) with an oral form of ampicillin in urinary tract infections]. | 1987 | 4 |
About Hiroyuki Shiro
Hiroyuki Shiro is a scholar working on Microbiology, Epidemiology and Clinical Biochemistry, having authored 23 papers that have together received 428 indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (9 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Bacterial Infections and Vaccines (5 papers), Respiratory viral infections research (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Respiratory and Cough-Related Research (2 papers), Streptococcal Infections and Treatments (2 papers) and Infective Endocarditis Diagnosis and Management (2 papers). The work is most often cited by research in Microbiology (94 citations), Clinical Biochemistry (68 citations) and Infectious Diseases (182 citations). Hiroyuki Shiro has collaborated with scholars based in Japan and United States. Frequent co-authors include Gerald B. Pier, E Müller, Donald A. Goldmann, S Takeda, Tor D. Tosteson, Robert D. Arbeit, Marianne Parent, Andrea Kropec, Johannes Hüebner and Joel N. Maslow. Their work appears in journals such as Circulation, The Journal of Infectious Diseases and The Journal of Pediatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.